Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report

Citations Over TimeTop 1% of 2017 papers

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

Related Papers

• → Targeting maladaptive glutathione responses in lung disease(2010)44 cited
• → Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022(2022)21 cited
• → GENDER-BASED DIFFERENCES IN HOSPITALIZATION RATES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM A DISEASE MANAGEMENT PROGRAM(2006)
• → HISTORIC DEVELOPMENT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE CLASSIFICATION(2018)
• → Diagnosing and Treating Chronic Obstructive Pulmonary Disease in 2024 – What Is New?(2024)